DK169566B1 - Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet - Google Patents

Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet Download PDF

Info

Publication number
DK169566B1
DK169566B1 DK037589A DK37589A DK169566B1 DK 169566 B1 DK169566 B1 DK 169566B1 DK 037589 A DK037589 A DK 037589A DK 37589 A DK37589 A DK 37589A DK 169566 B1 DK169566 B1 DK 169566B1
Authority
DK
Denmark
Prior art keywords
composition according
composition
methylthio
benzoyl
methyl
Prior art date
Application number
DK037589A
Other languages
Danish (da)
English (en)
Other versions
DK37589D0 (da
DK37589A (da
Inventor
Jack Domet
Douglas W Danielson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK37589D0 publication Critical patent/DK37589D0/da
Publication of DK37589A publication Critical patent/DK37589A/da
Application granted granted Critical
Publication of DK169566B1 publication Critical patent/DK169566B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK037589A 1988-01-29 1989-01-27 Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet DK169566B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14980388A 1988-01-29 1988-01-29
US14980388 1988-01-29

Publications (3)

Publication Number Publication Date
DK37589D0 DK37589D0 (da) 1989-01-27
DK37589A DK37589A (da) 1989-07-30
DK169566B1 true DK169566B1 (da) 1994-12-05

Family

ID=22531858

Family Applications (1)

Application Number Title Priority Date Filing Date
DK037589A DK169566B1 (da) 1988-01-29 1989-01-27 Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet

Country Status (17)

Country Link
EP (1) EP0326103B1 (fr)
JP (1) JPH01226817A (fr)
KR (1) KR890011594A (fr)
CN (1) CN1035242A (fr)
AR (1) AR241632A1 (fr)
AT (1) ATE78161T1 (fr)
AU (1) AU611757B2 (fr)
DE (1) DE68902056T2 (fr)
DK (1) DK169566B1 (fr)
ES (1) ES2051898T3 (fr)
GR (1) GR3005792T3 (fr)
HU (1) HUT49282A (fr)
IE (1) IE62426B1 (fr)
IL (1) IL89049A0 (fr)
NZ (1) NZ227700A (fr)
PT (1) PT89561B (fr)
ZA (1) ZA89552B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69129918T2 (de) * 1990-03-23 1999-02-04 Yoshitomi Pharmaceutical Ein in Wasser schwerlösliches Arzneimittel enthaltende pharmazeutische Zubereitung
EP1699436A2 (fr) * 2003-12-12 2006-09-13 Myogen, Inc. Preparations a base d'enoximone et leur utilisation pour traiter l'hypertrophie cardiaque et l'insuffisance cardiaque
CA2572179A1 (fr) * 2004-06-23 2006-01-19 Myogen, Inc. Formulations d'enoximone et utilisation dans le traitement de maladies a mediation par pde-iii
EP2581082B1 (fr) 2011-10-10 2015-12-30 Carinopharm GmbH Composition pharmaceutique pour le traitement d'un état de mal asthmatique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405635A (en) * 1979-06-18 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Aroylimidazol-2-ones and their use as pharmaceuticals
EP0031603A1 (fr) * 1979-12-31 1981-07-08 American Cyanamid Company Composition pharmaceutique
NZ197796A (en) * 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0179583A1 (fr) * 1984-10-04 1986-04-30 Merck & Co. Inc. Système pour augmenter la vitesse de dissolution dans l'eau et la solubilité de médicaments peu solubles

Also Published As

Publication number Publication date
DK37589D0 (da) 1989-01-27
ATE78161T1 (de) 1992-08-15
EP0326103A1 (fr) 1989-08-02
PT89561B (pt) 1994-01-31
CN1035242A (zh) 1989-09-06
IE62426B1 (en) 1995-02-08
NZ227700A (en) 1990-09-26
AR241632A1 (es) 1992-10-30
PT89561A (pt) 1989-10-04
KR890011594A (ko) 1989-08-21
ZA89552B (en) 1989-10-25
IL89049A0 (en) 1989-08-15
ES2051898T3 (es) 1994-07-01
HUT49282A (en) 1989-09-28
EP0326103B1 (fr) 1992-07-15
IE890275L (en) 1989-07-29
AU611757B2 (en) 1991-06-20
DE68902056T2 (de) 1992-12-03
JPH01226817A (ja) 1989-09-11
DE68902056D1 (de) 1992-08-20
DK37589A (da) 1989-07-30
GR3005792T3 (fr) 1993-06-07
AU2876889A (en) 1989-08-03

Similar Documents

Publication Publication Date Title
TWI490216B (zh) 用作ｃ型肝炎病毒蛋白酶抑制劑之醫藥組合物
JP3667778B2 (ja) スフェロイド製剤
JP3678745B2 (ja) 高濃度アセトアミノフェン溶液含有ゼラチンカプセル
EP1207872B1 (fr) Gels mous contenant de l'ibuprofene
US20110086844A1 (en) Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance
US6221391B1 (en) Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
JPH0667829B2 (ja) イブプロフエン含有ゼラチン軟カプセルおよびその製造方法
EP0277459A2 (fr) Médicament à libération controlée
WO1995031979A1 (fr) Solutions d'acides alcanoiques a substitution aryle ou heteroaryle dans des solvants lipophiles, et capsules de gelatine molle contenant de telles solutions
EP0706380B1 (fr) Medicament encapsule
DK169566B1 (da) Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet
US20020025338A1 (en) Bioavailable dosage form of isotrentinoin
US6352718B1 (en) Vasopressin antagonist formulation and process
WO2004062692A1 (fr) Formulation de substances actives a faible hydrosolubilite
JP2009501796A (ja) 睡眠薬の放出調整
EP3854384A1 (fr) Formulation pharmaceutique comprenant de l'acétate d'abiratérone
KR20020039354A (ko) 바소프레신 길항제 제형 및 방법
AU2002240206B2 (en) Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
AU2002240206A1 (en) Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle
WO2002013789A1 (fr) 4omposition pharmaceutique contenant 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl] -1-butyl]-spiro[isobenzofuran-1(3h),4'-piperidine]
MXPA06005247A (es) Composicion farmaceutica destinada a la administracion oral de un derivado de pirazol-3-carboxamida

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK